Refresh

ALEMBIC PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release


Download
04 Mar 2021
With reference to the captioned subject, this is to inform the exchange that the Company's joint venture, Aleor Dermaceuticals Limited, has received US Food and Drug Administration (USFDA) Final Approval for Testosterone Gel, 1.62% (20.25 mg/1.25 gm actuation).<BR> <BR> Please find enclosed herewith our press release.<BR> <BR> We request you to kindly take the same on record.<BR>

Source: BSE India

View all announcements for ALEMBIC PHARMACEUTICALS LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com